Macrophage FABP4 is required for neutrophil recruitment and bacterial clearance in Pseudomonas aeruginosa pneumonia

Fatty acid binding protein 4 (FABP4), an intracellular lipid chaperone and adipokine, is expressed by lung macrophages, but the function of macrophage–FABP4 remains elusive. We investigated the role of FABP4 in host defense in a murine model of Pseudomonas aeruginosa pneumonia. Compared with wild‐type (WT) mice, FABP4‐deficient (FABP4−/−) mice exhibited decreased bacterial clearance and increased mortality when challenged in‐tranasally with P. aeruginosa. These findings in FABP4−/− mice were associated with a delayed neutrophil recruitment into the lungs and were followed by greater acute lung injury and inflammation. Among leukocytes, only macrophages expressed FABP4 in WT mice with P. aeruginosa pneumonia. Chimeric FABP4−/− mice with WT bone marrow were protected from increased mortality seen in chimeric WT mice with FABP4−/− bone marrow during P. aeruginosa pneumonia, thus confirming the role of macrophages as the main source of protective FABP4 against that infection. There was less production of C‐X‐C motif chemokine ligand 1 (CXCL1) in FABP4−/− alveolar macrophages and lower airway CXCL1 levels in FABP4−/− mice. Delivering recombinant CXCL1 to the airways protected FABP4−/− mice from increased susceptibility to P. aeruginosa pneumonia. Thus, macrophage‐FABP4 has a novel role in pulmonary host defense against P. aeruginosa infection by facilitating crosstalk between macrophages and neutrophils via regulation of macrophage CXCL1 production.—Liang, X., Gupta, K., Rojas Quintero, J., Cernadas, M., Kobzik, L., Christou, H., Pier, G. B., Owen, C. A., çataltepe, S. Macrophage FABP4 is required for neutrophil recruitment and bacterial clearance in Pseudomonas aeruginosa pneumonia. FASEB J. 33,3562–3574 (2019). www.fasebj.org

[1]  E. Degerman,et al.  White to beige conversion in PDE3B KO adipose tissue through activation of AMPK signaling and mitochondrial function , 2017, Scientific Reports.

[2]  N. Møller,et al.  Regulation of Lipolysis and Adipose Tissue Signaling during Acute Endotoxin-Induced Inflammation: A Human Randomized Crossover Trial , 2016, PloS one.

[3]  T. van der Poll,et al.  Lung epithelial MyD88 drives early pulmonary clearance of Pseudomonas aeruginosa by a flagellin dependent mechanism. , 2016, American journal of physiology. Lung cellular and molecular physiology.

[4]  A. Tirosh,et al.  Development of a therapeutic monoclonal antibody that targets secreted fatty acid–binding protein aP2 to treat type 2 diabetes , 2015, Science Translational Medicine.

[5]  L. Gregory,et al.  Pulmonary macrophages: key players in the innate defence of the airways , 2015, Thorax.

[6]  T. W. Smith,et al.  Fatty acid binding protein 4 expression in cerebral vascular malformations: implications for vascular remodelling , 2015, Neuropathology and applied neurobiology.

[7]  Min Wang,et al.  The mAb against adipocyte fatty acid-binding protein 2E4 attenuates the inflammation in the mouse model of high-fat diet-induced obesity via toll-like receptor 4 pathway , 2015, Molecular and Cellular Endocrinology.

[8]  V. Salomaa,et al.  Low-Expression Variant of Fatty Acid–Binding Protein 4 Favors Reduced Manifestations of Atherosclerotic Disease and Increased Plaque Stability , 2014, Circulation. Cardiovascular genetics.

[9]  A. Anzueto,et al.  Antibiotics for treatment and prevention of exacerbations of chronic obstructive pulmonary disease. , 2013, The Journal of infection.

[10]  Marenao Tanaka,et al.  Circulating Levels of Fatty Acid-Binding Protein Family and Metabolic Phenotype in the General Population , 2013, PloS one.

[11]  J. Rello,et al.  Risk factors for Pseudomonas aeruginosa pneumonia in the early twenty-first century , 2013, Intensive Care Medicine.

[12]  H. Perlman,et al.  Flow cytometric analysis of macrophages and dendritic cell subsets in the mouse lung. , 2013, American journal of respiratory cell and molecular biology.

[13]  L. Boon,et al.  Lipocalin 2 deactivates macrophages and worsens pneumococcal pneumonia outcomes. , 2013, The Journal of clinical investigation.

[14]  E. Israel,et al.  Adam8 Limits the Development of Allergic Airway Inflammation in Mice , 2013, The Journal of Immunology.

[15]  G. Hotamisligil,et al.  Adipocyte lipid chaperone AP2 is a secreted adipokine regulating hepatic glucose production. , 2013, Cell metabolism.

[16]  J. Sousa,et al.  Pseudomonas aeruginosa infection in cystic fibrosis lung disease and new perspectives of treatment: a review , 2013, European Journal of Clinical Microbiology & Infectious Diseases.

[17]  S. Erzurum,et al.  Fatty acid binding protein 4 regulates VEGF-induced airway angiogenesis and inflammation in a transgenic mouse model: implications for asthma. , 2013, The American journal of pathology.

[18]  M. Merad,et al.  Systemic Analysis of PPARγ in Mouse Macrophage Populations Reveals Marked Diversity in Expression with Critical Roles in Resolution of Inflammation and Airway Immunity , 2012, The Journal of Immunology.

[19]  M. Sahin,et al.  Endothelial cell-fatty acid binding protein 4 promotes angiogenesis: role of stem cell factor/c-kit pathway , 2012, Angiogenesis.

[20]  S. Batra,et al.  Intrapulmonary Administration of Leukotriene B4 Augments Neutrophil Accumulation and Responses in the Lung to Klebsiella Infection in CXCL1 Knockout Mice , 2012, The Journal of Immunology.

[21]  L. Masana,et al.  FABP4 predicts atherogenic dyslipidemia development. The PREDIMED study. , 2011, Atherosclerosis.

[22]  S. Berkelhamer,et al.  Fatty acid-binding proteins and peribronchial angiogenesis in bronchopulmonary dysplasia. , 2011, American journal of respiratory cell and molecular biology.

[23]  Ji-Young Lee,et al.  Unsaturated fatty acids repress the expression of adipocyte fatty acid binding protein via the modulation of histone deacetylation in RAW 264.7 macrophages , 2011, European journal of nutrition.

[24]  L. Kobzik,et al.  MARCO regulates early inflammatory responses against influenza: a useful macrophage function with adverse outcome. , 2011, American journal of respiratory cell and molecular biology.

[25]  V. Yu,et al.  Pneumonia due to Pseudomonas aeruginosa: part II: antimicrobial resistance, pharmacodynamic concepts, and antibiotic therapy. , 2011, Chest.

[26]  J. Weingarten,et al.  Pneumonia due to Pseudomonas aeruginosa: part I: epidemiology, clinical diagnosis, and source. , 2011, Chest.

[27]  E. Gulbins,et al.  Kinase suppressor of Ras-1 protects against pulmonary Pseudomonas aeruginosa infections , 2011, Nature Medicine.

[28]  R. Evans,et al.  Feeder-dependent and feeder-independent iPS cell derivation from human and mouse adipose stem cells , 2011, Nature Protocols.

[29]  S. Batra,et al.  CXCL1 Regulates Pulmonary Host Defense to Klebsiella Infection via CXCL2, CXCL5, NF-κB, and MAPKs , 2010, The Journal of Immunology.

[30]  Baljit Singh,et al.  Monocyte and macrophage heterogeneity and Toll-like receptors in the lung , 2010, Cell and Tissue Research.

[31]  Jordi Rello,et al.  International study of the prevalence and outcomes of infection in intensive care units. , 2009, JAMA.

[32]  T. Ince,et al.  Fatty acid binding protein 4 is a target of VEGF and a regulator of cell proliferation in endothelial cells , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[33]  G. Pier,et al.  Inescapable Need for Neutrophils as Mediators of Cellular Innate Immunity to Acute Pseudomonas aeruginosa Pneumonia , 2009, Infection and Immunity.

[34]  T. Betsuyaku,et al.  Epilysin (MMP-28) Restrains Early Macrophage Recruitment in Pseudomonas aeruginosa Pneumonia1 , 2009, The Journal of Immunology.

[35]  M. Furuhashi,et al.  Adipocyte/macrophage fatty acid-binding proteins contribute to metabolic deterioration through actions in both macrophages and adipocytes in mice. , 2008, The Journal of clinical investigation.

[36]  M. Furuhashi,et al.  Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets , 2008, Nature Reviews Drug Discovery.

[37]  P. Sham,et al.  Serum Adipocyte Fatty Acid–Binding Protein as a New Biomarker Predicting the Development of Type 2 Diabetes , 2007, Diabetes Care.

[38]  R. Parker,et al.  Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2 , 2007, Nature.

[39]  E. Rimm,et al.  A genetic variant at the fatty acid-binding protein aP2 locus reduces the risk for hypertriglyceridemia, type 2 diabetes, and cardiovascular disease. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[40]  J. Suttles,et al.  The Fatty Acid-binding Protein, aP2, Coordinates Macrophage Cholesterol Trafficking and Inflammatory Activity , 2005, Journal of Biological Chemistry.

[41]  Janet S. Lee,et al.  Optimal timing to repopulation of resident alveolar macrophages with donor cells following total body irradiation and bone marrow transplantation in mice. , 2004, Journal of immunological methods.

[42]  K. Tryggvason,et al.  The Scavenger Receptor MARCO Is Required for Lung Defense against Pneumococcal Pneumonia and Inhaled Particles , 2004, The Journal of experimental medicine.

[43]  A. Richmond,et al.  Fine tuning the transcriptional regulation of the CXCL1 chemokine. , 2003, Progress in nucleic acid research and molecular biology.

[44]  W. Garvey,et al.  The adipocyte lipid binding protein (ALBP/aP2) gene facilitates foam cell formation in human THP-1 macrophages. , 2002, Atherosclerosis.

[45]  Jeffrey B. Boord,et al.  Adipocyte Fatty Acid–Binding Protein, aP2, Alters Late Atherosclerotic Lesion Formation in Severe Hypercholesterolemia , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[46]  Jeffrey B. Boord,et al.  Lack of macrophage fatty-acid–binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis , 2001, Nature Medicine.

[47]  D. Bernlohr,et al.  The Mammalian Fatty Acid-binding Protein Multigene Family: Molecular and Genetic Insights into Function , 2000, Trends in Endocrinology & Metabolism.

[48]  K. Kooguchi,et al.  Role of Alveolar Macrophages in Initiation and Regulation of Inflammation in Pseudomonas aeruginosaPneumonia , 1998, Infection and Immunity.

[49]  C. Morissette,et al.  Lung phagocyte bactericidal function in strains of mice resistant and susceptible to Pseudomonas aeruginosa , 1996, Infection and immunity.

[50]  Bruce M. Spiegelman,et al.  Uncoupling of Obesity from Insulin Resistance Through a Targeted Mutation in aP2, the Adipocyte Fatty Acid Binding Protein , 1996, Science.

[51]  J. Pittet,et al.  Depletion of alveolar macrophages decreases neutrophil chemotaxis to Pseudomonas airspace infections. , 1996, The American journal of physiology.